Global Targeted Drugs for Colorectal Cancer Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Targeted Drugs for Colorectal Cancer market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Targeted therapy is to design corresponding therapeutic drugs for the identified cancer-causing site (the site can be a protein molecule inside the tumor cell or a gene fragment) at the cellular molecular level, and the drug enters the body It will specifically select oncogenic sites to combine and act, so that tumor cells will die specifically, without affecting normal tissue cells around the tumor.
This report is a detailed and comprehensive analysis for global Targeted Drugs for Colorectal Cancer market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Targeted Drugs for Colorectal Cancer market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Targeted Drugs for Colorectal Cancer market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Targeted Drugs for Colorectal Cancer market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Targeted Drugs for Colorectal Cancer market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Targeted Drugs for Colorectal Cancer
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Targeted Drugs for Colorectal Cancer market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Amgen, F. Hoffmann-La Roche Ltd, Novartis and Array BioPharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Targeted Drugs for Colorectal Cancer market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Targeted Drugs for Colorectal Cancer product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Targeted Drugs for Colorectal Cancer, with price, sales, revenue and global market share of Targeted Drugs for Colorectal Cancer from 2018 to 2023.
Chapter 3, the Targeted Drugs for Colorectal Cancer competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Targeted Drugs for Colorectal Cancer breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Targeted Drugs for Colorectal Cancer market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Targeted Drugs for Colorectal Cancer.
Chapter 14 and 15, to describe Targeted Drugs for Colorectal Cancer sales channel, distributors, customers, research findings and conclusion.
Targeted therapy is to design corresponding therapeutic drugs for the identified cancer-causing site (the site can be a protein molecule inside the tumor cell or a gene fragment) at the cellular molecular level, and the drug enters the body It will specifically select oncogenic sites to combine and act, so that tumor cells will die specifically, without affecting normal tissue cells around the tumor.
This report is a detailed and comprehensive analysis for global Targeted Drugs for Colorectal Cancer market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Targeted Drugs for Colorectal Cancer market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Targeted Drugs for Colorectal Cancer market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Targeted Drugs for Colorectal Cancer market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Targeted Drugs for Colorectal Cancer market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Targeted Drugs for Colorectal Cancer
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Targeted Drugs for Colorectal Cancer market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Amgen, F. Hoffmann-La Roche Ltd, Novartis and Array BioPharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Targeted Drugs for Colorectal Cancer market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- EGFR Target
- BRAF Target
- MEK1/2 Targets
- BRAF V600 Target
- HER2 Target
- VEGFR-1/2/3 Targets
- PD-1 Target
- CTLA-4 Target
- Hospital
- Specialty Clinic
- Merck
- Amgen
- F. Hoffmann-La Roche Ltd
- Novartis
- Array BioPharma
- Genentech
- Bayer
- Sanofi
- Lilly
- Bristol myers squibb
- MSD lreland
- HUTCHMED
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Targeted Drugs for Colorectal Cancer product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Targeted Drugs for Colorectal Cancer, with price, sales, revenue and global market share of Targeted Drugs for Colorectal Cancer from 2018 to 2023.
Chapter 3, the Targeted Drugs for Colorectal Cancer competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Targeted Drugs for Colorectal Cancer breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Targeted Drugs for Colorectal Cancer market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Targeted Drugs for Colorectal Cancer.
Chapter 14 and 15, to describe Targeted Drugs for Colorectal Cancer sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Targeted Drugs for Colorectal Cancer
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Targeted Drugs for Colorectal Cancer Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 EGFR Target
1.3.3 BRAF Target
1.3.4 MEK1/2 Targets
1.3.5 BRAF V600 Target
1.3.6 HER2 Target
1.3.7 VEGFR-1/2/3 Targets
1.3.8 PD-1 Target
1.3.9 CTLA-4 Target
1.4 Market Analysis by Application
1.4.1 Overview: Global Targeted Drugs for Colorectal Cancer Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Specialty Clinic
1.5 Global Targeted Drugs for Colorectal Cancer Market Size & Forecast
1.5.1 Global Targeted Drugs for Colorectal Cancer Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Targeted Drugs for Colorectal Cancer Sales Quantity (2018-2029)
1.5.3 Global Targeted Drugs for Colorectal Cancer Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Targeted Drugs for Colorectal Cancer Product and Services
2.1.4 Merck Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Targeted Drugs for Colorectal Cancer Product and Services
2.2.4 Amgen Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Amgen Recent Developments/Updates
2.3 F. Hoffmann-La Roche Ltd
2.3.1 F. Hoffmann-La Roche Ltd Details
2.3.2 F. Hoffmann-La Roche Ltd Major Business
2.3.3 F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Product and Services
2.3.4 F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Targeted Drugs for Colorectal Cancer Product and Services
2.4.4 Novartis Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Novartis Recent Developments/Updates
2.5 Array BioPharma
2.5.1 Array BioPharma Details
2.5.2 Array BioPharma Major Business
2.5.3 Array BioPharma Targeted Drugs for Colorectal Cancer Product and Services
2.5.4 Array BioPharma Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Array BioPharma Recent Developments/Updates
2.6 Genentech
2.6.1 Genentech Details
2.6.2 Genentech Major Business
2.6.3 Genentech Targeted Drugs for Colorectal Cancer Product and Services
2.6.4 Genentech Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Genentech Recent Developments/Updates
2.7 Bayer
2.7.1 Bayer Details
2.7.2 Bayer Major Business
2.7.3 Bayer Targeted Drugs for Colorectal Cancer Product and Services
2.7.4 Bayer Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bayer Recent Developments/Updates
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Targeted Drugs for Colorectal Cancer Product and Services
2.8.4 Sanofi Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sanofi Recent Developments/Updates
2.9 Lilly
2.9.1 Lilly Details
2.9.2 Lilly Major Business
2.9.3 Lilly Targeted Drugs for Colorectal Cancer Product and Services
2.9.4 Lilly Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Lilly Recent Developments/Updates
2.10 Bristol myers squibb
2.10.1 Bristol myers squibb Details
2.10.2 Bristol myers squibb Major Business
2.10.3 Bristol myers squibb Targeted Drugs for Colorectal Cancer Product and Services
2.10.4 Bristol myers squibb Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Bristol myers squibb Recent Developments/Updates
2.11 MSD lreland
2.11.1 MSD lreland Details
2.11.2 MSD lreland Major Business
2.11.3 MSD lreland Targeted Drugs for Colorectal Cancer Product and Services
2.11.4 MSD lreland Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 MSD lreland Recent Developments/Updates
2.12 HUTCHMED
2.12.1 HUTCHMED Details
2.12.2 HUTCHMED Major Business
2.12.3 HUTCHMED Targeted Drugs for Colorectal Cancer Product and Services
2.12.4 HUTCHMED Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 HUTCHMED Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: TARGETED DRUGS FOR COLORECTAL CANCER BY MANUFACTURER
3.1 Global Targeted Drugs for Colorectal Cancer Sales Quantity by Manufacturer (2018-2023)
3.2 Global Targeted Drugs for Colorectal Cancer Revenue by Manufacturer (2018-2023)
3.3 Global Targeted Drugs for Colorectal Cancer Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Targeted Drugs for Colorectal Cancer by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Targeted Drugs for Colorectal Cancer Manufacturer Market Share in 2022
3.4.2 Top 6 Targeted Drugs for Colorectal Cancer Manufacturer Market Share in 2022
3.5 Targeted Drugs for Colorectal Cancer Market: Overall Company Footprint Analysis
3.5.1 Targeted Drugs for Colorectal Cancer Market: Region Footprint
3.5.2 Targeted Drugs for Colorectal Cancer Market: Company Product Type Footprint
3.5.3 Targeted Drugs for Colorectal Cancer Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Targeted Drugs for Colorectal Cancer Market Size by Region
4.1.1 Global Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2018-2029)
4.1.2 Global Targeted Drugs for Colorectal Cancer Consumption Value by Region (2018-2029)
4.1.3 Global Targeted Drugs for Colorectal Cancer Average Price by Region (2018-2029)
4.2 North America Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029)
4.3 Europe Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029)
4.4 Asia-Pacific Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029)
4.5 South America Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029)
4.6 Middle East and Africa Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2029)
5.2 Global Targeted Drugs for Colorectal Cancer Consumption Value by Type (2018-2029)
5.3 Global Targeted Drugs for Colorectal Cancer Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2029)
6.2 Global Targeted Drugs for Colorectal Cancer Consumption Value by Application (2018-2029)
6.3 Global Targeted Drugs for Colorectal Cancer Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2029)
7.2 North America Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2029)
7.3 North America Targeted Drugs for Colorectal Cancer Market Size by Country
7.3.1 North America Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2018-2029)
7.3.2 North America Targeted Drugs for Colorectal Cancer Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2029)
8.2 Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2029)
8.3 Europe Targeted Drugs for Colorectal Cancer Market Size by Country
8.3.1 Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2018-2029)
8.3.2 Europe Targeted Drugs for Colorectal Cancer Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Targeted Drugs for Colorectal Cancer Market Size by Region
9.3.1 Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Targeted Drugs for Colorectal Cancer Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2029)
10.2 South America Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2029)
10.3 South America Targeted Drugs for Colorectal Cancer Market Size by Country
10.3.1 South America Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2018-2029)
10.3.2 South America Targeted Drugs for Colorectal Cancer Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Targeted Drugs for Colorectal Cancer Market Size by Country
11.3.1 Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Targeted Drugs for Colorectal Cancer Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Targeted Drugs for Colorectal Cancer Market Drivers
12.2 Targeted Drugs for Colorectal Cancer Market Restraints
12.3 Targeted Drugs for Colorectal Cancer Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Targeted Drugs for Colorectal Cancer and Key Manufacturers
13.2 Manufacturing Costs Percentage of Targeted Drugs for Colorectal Cancer
13.3 Targeted Drugs for Colorectal Cancer Production Process
13.4 Targeted Drugs for Colorectal Cancer Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Targeted Drugs for Colorectal Cancer Typical Distributors
14.3 Targeted Drugs for Colorectal Cancer Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Targeted Drugs for Colorectal Cancer
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Targeted Drugs for Colorectal Cancer Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 EGFR Target
1.3.3 BRAF Target
1.3.4 MEK1/2 Targets
1.3.5 BRAF V600 Target
1.3.6 HER2 Target
1.3.7 VEGFR-1/2/3 Targets
1.3.8 PD-1 Target
1.3.9 CTLA-4 Target
1.4 Market Analysis by Application
1.4.1 Overview: Global Targeted Drugs for Colorectal Cancer Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Specialty Clinic
1.5 Global Targeted Drugs for Colorectal Cancer Market Size & Forecast
1.5.1 Global Targeted Drugs for Colorectal Cancer Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Targeted Drugs for Colorectal Cancer Sales Quantity (2018-2029)
1.5.3 Global Targeted Drugs for Colorectal Cancer Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Targeted Drugs for Colorectal Cancer Product and Services
2.1.4 Merck Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Targeted Drugs for Colorectal Cancer Product and Services
2.2.4 Amgen Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Amgen Recent Developments/Updates
2.3 F. Hoffmann-La Roche Ltd
2.3.1 F. Hoffmann-La Roche Ltd Details
2.3.2 F. Hoffmann-La Roche Ltd Major Business
2.3.3 F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Product and Services
2.3.4 F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Targeted Drugs for Colorectal Cancer Product and Services
2.4.4 Novartis Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Novartis Recent Developments/Updates
2.5 Array BioPharma
2.5.1 Array BioPharma Details
2.5.2 Array BioPharma Major Business
2.5.3 Array BioPharma Targeted Drugs for Colorectal Cancer Product and Services
2.5.4 Array BioPharma Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Array BioPharma Recent Developments/Updates
2.6 Genentech
2.6.1 Genentech Details
2.6.2 Genentech Major Business
2.6.3 Genentech Targeted Drugs for Colorectal Cancer Product and Services
2.6.4 Genentech Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Genentech Recent Developments/Updates
2.7 Bayer
2.7.1 Bayer Details
2.7.2 Bayer Major Business
2.7.3 Bayer Targeted Drugs for Colorectal Cancer Product and Services
2.7.4 Bayer Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bayer Recent Developments/Updates
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Targeted Drugs for Colorectal Cancer Product and Services
2.8.4 Sanofi Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sanofi Recent Developments/Updates
2.9 Lilly
2.9.1 Lilly Details
2.9.2 Lilly Major Business
2.9.3 Lilly Targeted Drugs for Colorectal Cancer Product and Services
2.9.4 Lilly Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Lilly Recent Developments/Updates
2.10 Bristol myers squibb
2.10.1 Bristol myers squibb Details
2.10.2 Bristol myers squibb Major Business
2.10.3 Bristol myers squibb Targeted Drugs for Colorectal Cancer Product and Services
2.10.4 Bristol myers squibb Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Bristol myers squibb Recent Developments/Updates
2.11 MSD lreland
2.11.1 MSD lreland Details
2.11.2 MSD lreland Major Business
2.11.3 MSD lreland Targeted Drugs for Colorectal Cancer Product and Services
2.11.4 MSD lreland Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 MSD lreland Recent Developments/Updates
2.12 HUTCHMED
2.12.1 HUTCHMED Details
2.12.2 HUTCHMED Major Business
2.12.3 HUTCHMED Targeted Drugs for Colorectal Cancer Product and Services
2.12.4 HUTCHMED Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 HUTCHMED Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: TARGETED DRUGS FOR COLORECTAL CANCER BY MANUFACTURER
3.1 Global Targeted Drugs for Colorectal Cancer Sales Quantity by Manufacturer (2018-2023)
3.2 Global Targeted Drugs for Colorectal Cancer Revenue by Manufacturer (2018-2023)
3.3 Global Targeted Drugs for Colorectal Cancer Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Targeted Drugs for Colorectal Cancer by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Targeted Drugs for Colorectal Cancer Manufacturer Market Share in 2022
3.4.2 Top 6 Targeted Drugs for Colorectal Cancer Manufacturer Market Share in 2022
3.5 Targeted Drugs for Colorectal Cancer Market: Overall Company Footprint Analysis
3.5.1 Targeted Drugs for Colorectal Cancer Market: Region Footprint
3.5.2 Targeted Drugs for Colorectal Cancer Market: Company Product Type Footprint
3.5.3 Targeted Drugs for Colorectal Cancer Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Targeted Drugs for Colorectal Cancer Market Size by Region
4.1.1 Global Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2018-2029)
4.1.2 Global Targeted Drugs for Colorectal Cancer Consumption Value by Region (2018-2029)
4.1.3 Global Targeted Drugs for Colorectal Cancer Average Price by Region (2018-2029)
4.2 North America Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029)
4.3 Europe Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029)
4.4 Asia-Pacific Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029)
4.5 South America Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029)
4.6 Middle East and Africa Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2029)
5.2 Global Targeted Drugs for Colorectal Cancer Consumption Value by Type (2018-2029)
5.3 Global Targeted Drugs for Colorectal Cancer Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2029)
6.2 Global Targeted Drugs for Colorectal Cancer Consumption Value by Application (2018-2029)
6.3 Global Targeted Drugs for Colorectal Cancer Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2029)
7.2 North America Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2029)
7.3 North America Targeted Drugs for Colorectal Cancer Market Size by Country
7.3.1 North America Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2018-2029)
7.3.2 North America Targeted Drugs for Colorectal Cancer Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2029)
8.2 Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2029)
8.3 Europe Targeted Drugs for Colorectal Cancer Market Size by Country
8.3.1 Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2018-2029)
8.3.2 Europe Targeted Drugs for Colorectal Cancer Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Targeted Drugs for Colorectal Cancer Market Size by Region
9.3.1 Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Targeted Drugs for Colorectal Cancer Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2029)
10.2 South America Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2029)
10.3 South America Targeted Drugs for Colorectal Cancer Market Size by Country
10.3.1 South America Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2018-2029)
10.3.2 South America Targeted Drugs for Colorectal Cancer Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Targeted Drugs for Colorectal Cancer Market Size by Country
11.3.1 Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Targeted Drugs for Colorectal Cancer Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Targeted Drugs for Colorectal Cancer Market Drivers
12.2 Targeted Drugs for Colorectal Cancer Market Restraints
12.3 Targeted Drugs for Colorectal Cancer Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Targeted Drugs for Colorectal Cancer and Key Manufacturers
13.2 Manufacturing Costs Percentage of Targeted Drugs for Colorectal Cancer
13.3 Targeted Drugs for Colorectal Cancer Production Process
13.4 Targeted Drugs for Colorectal Cancer Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Targeted Drugs for Colorectal Cancer Typical Distributors
14.3 Targeted Drugs for Colorectal Cancer Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Targeted Drugs for Colorectal Cancer Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Targeted Drugs for Colorectal Cancer Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Targeted Drugs for Colorectal Cancer Product and Services
Table 6. Merck Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. Amgen Basic Information, Manufacturing Base and Competitors
Table 9. Amgen Major Business
Table 10. Amgen Targeted Drugs for Colorectal Cancer Product and Services
Table 11. Amgen Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Amgen Recent Developments/Updates
Table 13. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 14. F. Hoffmann-La Roche Ltd Major Business
Table 15. F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Product and Services
Table 16. F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 18. Novartis Basic Information, Manufacturing Base and Competitors
Table 19. Novartis Major Business
Table 20. Novartis Targeted Drugs for Colorectal Cancer Product and Services
Table 21. Novartis Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Novartis Recent Developments/Updates
Table 23. Array BioPharma Basic Information, Manufacturing Base and Competitors
Table 24. Array BioPharma Major Business
Table 25. Array BioPharma Targeted Drugs for Colorectal Cancer Product and Services
Table 26. Array BioPharma Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Array BioPharma Recent Developments/Updates
Table 28. Genentech Basic Information, Manufacturing Base and Competitors
Table 29. Genentech Major Business
Table 30. Genentech Targeted Drugs for Colorectal Cancer Product and Services
Table 31. Genentech Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Genentech Recent Developments/Updates
Table 33. Bayer Basic Information, Manufacturing Base and Competitors
Table 34. Bayer Major Business
Table 35. Bayer Targeted Drugs for Colorectal Cancer Product and Services
Table 36. Bayer Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Bayer Recent Developments/Updates
Table 38. Sanofi Basic Information, Manufacturing Base and Competitors
Table 39. Sanofi Major Business
Table 40. Sanofi Targeted Drugs for Colorectal Cancer Product and Services
Table 41. Sanofi Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sanofi Recent Developments/Updates
Table 43. Lilly Basic Information, Manufacturing Base and Competitors
Table 44. Lilly Major Business
Table 45. Lilly Targeted Drugs for Colorectal Cancer Product and Services
Table 46. Lilly Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Lilly Recent Developments/Updates
Table 48. Bristol myers squibb Basic Information, Manufacturing Base and Competitors
Table 49. Bristol myers squibb Major Business
Table 50. Bristol myers squibb Targeted Drugs for Colorectal Cancer Product and Services
Table 51. Bristol myers squibb Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Bristol myers squibb Recent Developments/Updates
Table 53. MSD lreland Basic Information, Manufacturing Base and Competitors
Table 54. MSD lreland Major Business
Table 55. MSD lreland Targeted Drugs for Colorectal Cancer Product and Services
Table 56. MSD lreland Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. MSD lreland Recent Developments/Updates
Table 58. HUTCHMED Basic Information, Manufacturing Base and Competitors
Table 59. HUTCHMED Major Business
Table 60. HUTCHMED Targeted Drugs for Colorectal Cancer Product and Services
Table 61. HUTCHMED Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. HUTCHMED Recent Developments/Updates
Table 63. Global Targeted Drugs for Colorectal Cancer Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Targeted Drugs for Colorectal Cancer Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Targeted Drugs for Colorectal Cancer Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Targeted Drugs for Colorectal Cancer, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Targeted Drugs for Colorectal Cancer Production Site of Key Manufacturer
Table 68. Targeted Drugs for Colorectal Cancer Market: Company Product Type Footprint
Table 69. Targeted Drugs for Colorectal Cancer Market: Company Product Application Footprint
Table 70. Targeted Drugs for Colorectal Cancer New Market Entrants and Barriers to Market Entry
Table 71. Targeted Drugs for Colorectal Cancer Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Targeted Drugs for Colorectal Cancer Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Targeted Drugs for Colorectal Cancer Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Targeted Drugs for Colorectal Cancer Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Targeted Drugs for Colorectal Cancer Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Targeted Drugs for Colorectal Cancer Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Targeted Drugs for Colorectal Cancer Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Targeted Drugs for Colorectal Cancer Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Targeted Drugs for Colorectal Cancer Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Targeted Drugs for Colorectal Cancer Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Targeted Drugs for Colorectal Cancer Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Targeted Drugs for Colorectal Cancer Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Targeted Drugs for Colorectal Cancer Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Targeted Drugs for Colorectal Cancer Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Targeted Drugs for Colorectal Cancer Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Targeted Drugs for Colorectal Cancer Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Targeted Drugs for Colorectal Cancer Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Targeted Drugs for Colorectal Cancer Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Targeted Drugs for Colorectal Cancer Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Targeted Drugs for Colorectal Cancer Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Targeted Drugs for Colorectal Cancer Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Targeted Drugs for Colorectal Cancer Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Targeted Drugs for Colorectal Cancer Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Targeted Drugs for Colorectal Cancer Raw Material
Table 131. Key Manufacturers of Targeted Drugs for Colorectal Cancer Raw Materials
Table 132. Targeted Drugs for Colorectal Cancer Typical Distributors
Table 133. Targeted Drugs for Colorectal Cancer Typical Customers
Table 1. Global Targeted Drugs for Colorectal Cancer Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Targeted Drugs for Colorectal Cancer Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Targeted Drugs for Colorectal Cancer Product and Services
Table 6. Merck Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. Amgen Basic Information, Manufacturing Base and Competitors
Table 9. Amgen Major Business
Table 10. Amgen Targeted Drugs for Colorectal Cancer Product and Services
Table 11. Amgen Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Amgen Recent Developments/Updates
Table 13. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 14. F. Hoffmann-La Roche Ltd Major Business
Table 15. F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Product and Services
Table 16. F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 18. Novartis Basic Information, Manufacturing Base and Competitors
Table 19. Novartis Major Business
Table 20. Novartis Targeted Drugs for Colorectal Cancer Product and Services
Table 21. Novartis Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Novartis Recent Developments/Updates
Table 23. Array BioPharma Basic Information, Manufacturing Base and Competitors
Table 24. Array BioPharma Major Business
Table 25. Array BioPharma Targeted Drugs for Colorectal Cancer Product and Services
Table 26. Array BioPharma Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Array BioPharma Recent Developments/Updates
Table 28. Genentech Basic Information, Manufacturing Base and Competitors
Table 29. Genentech Major Business
Table 30. Genentech Targeted Drugs for Colorectal Cancer Product and Services
Table 31. Genentech Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Genentech Recent Developments/Updates
Table 33. Bayer Basic Information, Manufacturing Base and Competitors
Table 34. Bayer Major Business
Table 35. Bayer Targeted Drugs for Colorectal Cancer Product and Services
Table 36. Bayer Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Bayer Recent Developments/Updates
Table 38. Sanofi Basic Information, Manufacturing Base and Competitors
Table 39. Sanofi Major Business
Table 40. Sanofi Targeted Drugs for Colorectal Cancer Product and Services
Table 41. Sanofi Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sanofi Recent Developments/Updates
Table 43. Lilly Basic Information, Manufacturing Base and Competitors
Table 44. Lilly Major Business
Table 45. Lilly Targeted Drugs for Colorectal Cancer Product and Services
Table 46. Lilly Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Lilly Recent Developments/Updates
Table 48. Bristol myers squibb Basic Information, Manufacturing Base and Competitors
Table 49. Bristol myers squibb Major Business
Table 50. Bristol myers squibb Targeted Drugs for Colorectal Cancer Product and Services
Table 51. Bristol myers squibb Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Bristol myers squibb Recent Developments/Updates
Table 53. MSD lreland Basic Information, Manufacturing Base and Competitors
Table 54. MSD lreland Major Business
Table 55. MSD lreland Targeted Drugs for Colorectal Cancer Product and Services
Table 56. MSD lreland Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. MSD lreland Recent Developments/Updates
Table 58. HUTCHMED Basic Information, Manufacturing Base and Competitors
Table 59. HUTCHMED Major Business
Table 60. HUTCHMED Targeted Drugs for Colorectal Cancer Product and Services
Table 61. HUTCHMED Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. HUTCHMED Recent Developments/Updates
Table 63. Global Targeted Drugs for Colorectal Cancer Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Targeted Drugs for Colorectal Cancer Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Targeted Drugs for Colorectal Cancer Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Targeted Drugs for Colorectal Cancer, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Targeted Drugs for Colorectal Cancer Production Site of Key Manufacturer
Table 68. Targeted Drugs for Colorectal Cancer Market: Company Product Type Footprint
Table 69. Targeted Drugs for Colorectal Cancer Market: Company Product Application Footprint
Table 70. Targeted Drugs for Colorectal Cancer New Market Entrants and Barriers to Market Entry
Table 71. Targeted Drugs for Colorectal Cancer Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Targeted Drugs for Colorectal Cancer Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Targeted Drugs for Colorectal Cancer Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Targeted Drugs for Colorectal Cancer Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Targeted Drugs for Colorectal Cancer Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Targeted Drugs for Colorectal Cancer Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Targeted Drugs for Colorectal Cancer Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Targeted Drugs for Colorectal Cancer Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Targeted Drugs for Colorectal Cancer Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Targeted Drugs for Colorectal Cancer Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Targeted Drugs for Colorectal Cancer Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Targeted Drugs for Colorectal Cancer Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Targeted Drugs for Colorectal Cancer Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Targeted Drugs for Colorectal Cancer Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Targeted Drugs for Colorectal Cancer Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Targeted Drugs for Colorectal Cancer Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Targeted Drugs for Colorectal Cancer Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Targeted Drugs for Colorectal Cancer Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Targeted Drugs for Colorectal Cancer Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Targeted Drugs for Colorectal Cancer Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Targeted Drugs for Colorectal Cancer Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Targeted Drugs for Colorectal Cancer Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Targeted Drugs for Colorectal Cancer Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Targeted Drugs for Colorectal Cancer Raw Material
Table 131. Key Manufacturers of Targeted Drugs for Colorectal Cancer Raw Materials
Table 132. Targeted Drugs for Colorectal Cancer Typical Distributors
Table 133. Targeted Drugs for Colorectal Cancer Typical Customers
LIST OF FIGURES
Figure 1. Targeted Drugs for Colorectal Cancer Picture
Figure 2. Global Targeted Drugs for Colorectal Cancer Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Type in 2022
Figure 4. EGFR Target Examples
Figure 5. BRAF Target Examples
Figure 6. MEK1/2 Targets Examples
Figure 7. BRAF V600 Target Examples
Figure 8. HER2 Target Examples
Figure 9. VEGFR-1/2/3 Targets Examples
Figure 10. PD-1 Target Examples
Figure 11. CTLA-4 Target Examples
Figure 12. Global Targeted Drugs for Colorectal Cancer Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 13. Global Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Application in 2022
Figure 14. Hospital Examples
Figure 15. Specialty Clinic Examples
Figure 16. Global Targeted Drugs for Colorectal Cancer Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global Targeted Drugs for Colorectal Cancer Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global Targeted Drugs for Colorectal Cancer Sales Quantity (2018-2029) & (K Units)
Figure 19. Global Targeted Drugs for Colorectal Cancer Average Price (2018-2029) & (US$/Unit)
Figure 20. Global Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Manufacturer in 2022
Figure 21. Global Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Manufacturer in 2022
Figure 22. Producer Shipments of Targeted Drugs for Colorectal Cancer by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 23. Top 3 Targeted Drugs for Colorectal Cancer Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Top 6 Targeted Drugs for Colorectal Cancer Manufacturer (Consumption Value) Market Share in 2022
Figure 25. Global Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Region (2018-2029)
Figure 26. Global Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Region (2018-2029)
Figure 27. North America Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029) & (USD Million)
Figure 28. Europe Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029) & (USD Million)
Figure 29. Asia-Pacific Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029) & (USD Million)
Figure 30. South America Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029) & (USD Million)
Figure 31. Middle East & Africa Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029) & (USD Million)
Figure 32. Global Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Type (2018-2029)
Figure 33. Global Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Type (2018-2029)
Figure 34. Global Targeted Drugs for Colorectal Cancer Average Price by Type (2018-2029) & (US$/Unit)
Figure 35. Global Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Application (2018-2029)
Figure 36. Global Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Application (2018-2029)
Figure 37. Global Targeted Drugs for Colorectal Cancer Average Price by Application (2018-2029) & (US$/Unit)
Figure 38. North America Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Type (2018-2029)
Figure 39. North America Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Application (2018-2029)
Figure 40. North America Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Country (2018-2029)
Figure 41. North America Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Country (2018-2029)
Figure 42. United States Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Canada Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Mexico Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Europe Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Type (2018-2029)
Figure 46. Europe Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Application (2018-2029)
Figure 47. Europe Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Country (2018-2029)
Figure 48. Europe Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Country (2018-2029)
Figure 49. Germany Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. France Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. United Kingdom Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Russia Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Italy Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Type (2018-2029)
Figure 55. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Application (2018-2029)
Figure 56. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Region (2018-2029)
Figure 57. Asia-Pacific Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Region (2018-2029)
Figure 58. China Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Japan Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Korea Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. India Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Southeast Asia Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Australia Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. South America Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Type (2018-2029)
Figure 65. South America Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Application (2018-2029)
Figure 66. South America Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Country (2018-2029)
Figure 67. South America Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Country (2018-2029)
Figure 68. Brazil Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Argentina Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Type (2018-2029)
Figure 71. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Application (2018-2029)
Figure 72. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Region (2018-2029)
Figure 73. Middle East & Africa Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Region (2018-2029)
Figure 74. Turkey Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Egypt Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Saudi Arabia Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. South Africa Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. Targeted Drugs for Colorectal Cancer Market Drivers
Figure 79. Targeted Drugs for Colorectal Cancer Market Restraints
Figure 80. Targeted Drugs for Colorectal Cancer Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Targeted Drugs for Colorectal Cancer in 2022
Figure 83. Manufacturing Process Analysis of Targeted Drugs for Colorectal Cancer
Figure 84. Targeted Drugs for Colorectal Cancer Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
Figure 1. Targeted Drugs for Colorectal Cancer Picture
Figure 2. Global Targeted Drugs for Colorectal Cancer Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Type in 2022
Figure 4. EGFR Target Examples
Figure 5. BRAF Target Examples
Figure 6. MEK1/2 Targets Examples
Figure 7. BRAF V600 Target Examples
Figure 8. HER2 Target Examples
Figure 9. VEGFR-1/2/3 Targets Examples
Figure 10. PD-1 Target Examples
Figure 11. CTLA-4 Target Examples
Figure 12. Global Targeted Drugs for Colorectal Cancer Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 13. Global Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Application in 2022
Figure 14. Hospital Examples
Figure 15. Specialty Clinic Examples
Figure 16. Global Targeted Drugs for Colorectal Cancer Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global Targeted Drugs for Colorectal Cancer Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global Targeted Drugs for Colorectal Cancer Sales Quantity (2018-2029) & (K Units)
Figure 19. Global Targeted Drugs for Colorectal Cancer Average Price (2018-2029) & (US$/Unit)
Figure 20. Global Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Manufacturer in 2022
Figure 21. Global Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Manufacturer in 2022
Figure 22. Producer Shipments of Targeted Drugs for Colorectal Cancer by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 23. Top 3 Targeted Drugs for Colorectal Cancer Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Top 6 Targeted Drugs for Colorectal Cancer Manufacturer (Consumption Value) Market Share in 2022
Figure 25. Global Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Region (2018-2029)
Figure 26. Global Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Region (2018-2029)
Figure 27. North America Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029) & (USD Million)
Figure 28. Europe Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029) & (USD Million)
Figure 29. Asia-Pacific Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029) & (USD Million)
Figure 30. South America Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029) & (USD Million)
Figure 31. Middle East & Africa Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029) & (USD Million)
Figure 32. Global Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Type (2018-2029)
Figure 33. Global Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Type (2018-2029)
Figure 34. Global Targeted Drugs for Colorectal Cancer Average Price by Type (2018-2029) & (US$/Unit)
Figure 35. Global Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Application (2018-2029)
Figure 36. Global Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Application (2018-2029)
Figure 37. Global Targeted Drugs for Colorectal Cancer Average Price by Application (2018-2029) & (US$/Unit)
Figure 38. North America Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Type (2018-2029)
Figure 39. North America Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Application (2018-2029)
Figure 40. North America Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Country (2018-2029)
Figure 41. North America Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Country (2018-2029)
Figure 42. United States Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Canada Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Mexico Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Europe Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Type (2018-2029)
Figure 46. Europe Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Application (2018-2029)
Figure 47. Europe Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Country (2018-2029)
Figure 48. Europe Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Country (2018-2029)
Figure 49. Germany Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. France Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. United Kingdom Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Russia Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Italy Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Type (2018-2029)
Figure 55. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Application (2018-2029)
Figure 56. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Region (2018-2029)
Figure 57. Asia-Pacific Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Region (2018-2029)
Figure 58. China Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Japan Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Korea Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. India Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Southeast Asia Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Australia Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. South America Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Type (2018-2029)
Figure 65. South America Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Application (2018-2029)
Figure 66. South America Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Country (2018-2029)
Figure 67. South America Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Country (2018-2029)
Figure 68. Brazil Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Argentina Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Type (2018-2029)
Figure 71. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Application (2018-2029)
Figure 72. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Region (2018-2029)
Figure 73. Middle East & Africa Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Region (2018-2029)
Figure 74. Turkey Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Egypt Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Saudi Arabia Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. South Africa Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. Targeted Drugs for Colorectal Cancer Market Drivers
Figure 79. Targeted Drugs for Colorectal Cancer Market Restraints
Figure 80. Targeted Drugs for Colorectal Cancer Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Targeted Drugs for Colorectal Cancer in 2022
Figure 83. Manufacturing Process Analysis of Targeted Drugs for Colorectal Cancer
Figure 84. Targeted Drugs for Colorectal Cancer Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
